LI Wenyan 1,2,3,4 , ZENG Linan 2,3,4 , LI Siyu 2,3,4 , NI Xiaofeng 2,3,4 , YI Qiusha 2,3,4 , ZHANG Chuan 2,3,4 , JIA Zhijun 1,2,3,4 , LIU Hanming 4,5 , ZHANG Lingli 1,2,3,4
  • 1. West China School of Pharmacy, Sichuan University, Chengdu 610041, P.R.China;
  • 2. Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu 610041, P.R.China;
  • 3. Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu 610041, P.R.China;
  • 4. Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, P.R.China;
  • 5. Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, P.R.China;
ZHANG Lingli, Email: zhanglingli@scu.edu.cn
Export PDF Favorites Scan Get Citation

Objective To analyze the current status of children's clinical practice guidelines from 2010 to 2021, and to evaluate the quality of evidence-based guidelines for children. Methods PubMed, EMbase, CNKI, WanFang Data, and VIP databases and relevant domestic and foreign guideline websites were searched to collect Chinese pediatric clinical guidelines from January 1st 2010 to September 13th 2021. Two reviewers independently screened literature, extracted data; 4 reviewers used AGREE Ⅱ to evaluate the quality of the included evidence-based guidelines. Results A total of 164 guidelines were included, which involved 65 evidence-based guidelines and 99 non-evidence-based guidelines, 113 western medicine guidelines and 51 traditional Chinese medicine guidelines. The majority of the diseases with high hospitalization burden were covered by those guidelines, including 35 guidelines for respiratory diseases, ranking first among all diseases. However, there was no guideline for pediatric cardiovascular disease in China. The average scores for 65 evidence-based guidelines in 6 individual domains were 65.2%, 49.6%, 59.3%, 68.5%, 23.9% and 83.6%. Conclusions The scores for applicability, stakeholder involvement, and rigor of development are low for Chinese guideline for children. There is a lack of pediatric clinical guidelines for circulatory disorders.

Citation: LI Wenyan, ZENG Linan, LI Siyu, NI Xiaofeng, YI Qiusha, ZHANG Chuan, JIA Zhijun, LIU Hanming, ZHANG Lingli. Analysis on status of clinical guidelines and evaluation of evidence-based clinical guidelines for children in China. Chinese Journal of Evidence-Based Medicine, 2021, 21(12): 1450-1456. doi: 10.7507/1672-2531.202108191 Copy

  • Previous Article

    Treatment with charged-particle radiation therapy: an overview of systematic reviews
  • Next Article

    Application of GRADE in Chinese clinical practice guidelines/expert consensus